CCM
Chiron Capital Management Portfolio holdings
AUM
$115M
1-Year Return
10.94%
This Quarter Return
-0.12%
1 Year Return
+10.94%
3 Year Return
+16.4%
5 Year Return
+25.95%
10 Year Return
–
AUM
$110M
AUM Growth
+$4.1M
(+3.9%)
Cap. Flow
+$2.97M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
40.08%
Holding
131
New
18
Increased
37
Reduced
44
Closed
17
Top Buys
| 1 |
United Parcel Service
UPS
|
+$2.43M |
| 2 |
Constellation Brands
STZ
|
+$1.39M |
| 3 |
Comcast
CMCSA
|
+$1.14M |
| 4 |
Nike
NKE
|
+$1.1M |
| 5 |
Diageo
DEO
|
+$943K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.7M |
| 2 |
Gilead Sciences
GILD
|
+$1.4M |
| 3 |
CVS Health
CVS
|
+$705K |
| 4 |
Citigroup
C
|
+$646K |
| 5 |
Medtronic
MDT
|
+$593K |
Sector Composition
| 1 | Healthcare | 27.46% |
| 2 | Consumer Staples | 11.73% |
| 3 | Consumer Discretionary | 8.64% |
| 4 | Communication Services | 7.72% |
| 5 | Technology | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$94B
| $18.3M | 16.61% |
299,608
-109,920
| -27% | -$6.7M |
|
2
SPDR S&P Biotech ETF
XBI
$5.43B
| $6.8M | 6.18% |
83,895
-3,307
| -4% | -$268K |
|
3
Crown Castle
CCI
$41.5B
| $2.71M | 2.47% |
26,033
+8,908
| +52% | +$928K |
|
|
4
Nike
NKE
$108B
| $2.64M | 2.4% |
41,523
+17,301
| +71% | +$1.1M |
|
5
Aflac
AFL
$58.4B
| $2.59M | 2.35% |
23,258
| – | – |
|
|
6
United Parcel Service
UPS
$71.5B
| $2.43M | 2.21% |
+22,072
| New | +$2.43M |
|
7
Apple
AAPL
$3.47T
| $2.38M | 2.17% |
10,734
-276
| -3% | -$61.3K |
|
8
Enterprise Products Partners
EPD
$68.8B
| $2.33M | 2.12% |
68,367
-1,350
| -2% | -$46.1K |
|
9
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.23B
| $2.04M | 1.86% |
80,068
-2,769
| -3% | -$70.7K |
|
10
Pfizer
PFE
$136B
| $1.9M | 1.73% |
75,035
+14,740
| +24% | +$374K |
|
|
11
Diageo
DEO
$56.5B
| $1.87M | 1.7% |
17,805
+8,996
| +102% | +$943K |
|
12
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$601M
| $1.8M | 1.63% |
89,931
+5,126
| +6% | +$102K |
|
13
Verizon
VZ
$185B
| $1.71M | 1.55% |
37,634
+13,703
| +57% | +$622K |
|
14
Merck
MRK
$207B
| $1.64M | 1.49% |
18,239
+8,005
| +78% | +$719K |
|
|
15
Comcast
CMCSA
$122B
| $1.63M | 1.48% |
44,138
+30,811
| +231% | +$1.14M |
|
16
Humana
HUM
$33.2B
| $1.59M | 1.44% |
6,003
+3,000
| +100% | +$794K |
|
17
Estee Lauder
EL
$30.1B
| $1.52M | 1.38% |
23,013
+10,797
| +88% | +$713K |
|
18
Amazon
AMZN
$2.43T
| $1.4M | 1.27% |
7,336
-121
| -2% | -$23K |
|
|
19
Constellation Brands
STZ
$24.6B
| $1.39M | 1.27% |
+7,601
| New | +$1.39M |
|
20
NVIDIA
NVDA
$4.33T
| $1.39M | 1.27% |
12,856
+1,160
| +10% | +$126K |
|
21
Kraft Heinz
KHC
$30.9B
| $1.34M | 1.22% |
44,114
+14,200
| +47% | +$432K |
|
22
Microsoft
MSFT
$3.79T
| $1.2M | 1.09% |
3,205
+518
| +19% | +$194K |
|
23
Raymond James Financial
RJF
$33.9B
| $1.2M | 1.09% |
8,650
| – | – |
|
|
24
Medtronic
MDT
$121B
| $1.19M | 1.08% |
13,251
-6,601
| -33% | -$593K |
|
|
25
Gilead Sciences
GILD
$142B
| $1.17M | 1.06% |
10,423
-12,451
| -54% | -$1.4M |
|